The Stock2Me Podcast
The Stock2Me Podcast is your source for the latest news and updates on market trends and movers in high-profile industry sectors. We’ll keep you in the loop regarding the companies on our watchlist and provide in-depth information about the inner workings and eccentricities of the ever-evolving North American markets. https://www.stock2me.com
Episodes
Stock2Me’s latest podcast features Dr. Alan Baratz, CEO of D-Wave Quantum Inc. (NYSE: QBTS), a leader in quantum computing systems, software and services that delivers customer value via practical quantum applications for computationally complex problems such as factory planning, resource allocation, job shop scheduling, labor allocation, vehicle routing, artificial intelligence, drug discovery, financial modeling and more.
During ...
Stock2Me’s latest podcast features Dr. Alan Baratz, CEO of D-Wave Quantum Inc. (NYSE: QBTS), a leader in quantum computing systems, software and services that delivers customer value via practical quantum applications for computationally complex problems such as factory planning, resource allocation, job shop scheduling, labor allocation, vehicle routing, artificial intelligence, drug discovery, financial modeling and more.
During ...
Stock2Me’s latest podcast features Joel Fruendt, President and CEO of SenesTech Inc. (NASDAQ: SNES), the leader in fertility control to manage animal pest populations.
To begin the interview, Fruendt provided an introduction to SenesTech’s business model and operating markets.
“SenesTech is a biotech and life sciences company that develops, patents and commercializes product formulations for fertility control of animal pests. Our m...
Stock2Me’s latest podcast features Joel Fruendt, President and CEO of SenesTech Inc. (NASDAQ: SNES), the leader in fertility control to manage animal pest populations.
To begin the interview, Fruendt provided an introduction to SenesTech’s business model and operating markets.
“SenesTech is a biotech and life sciences company that develops, patents and commercializes product formulations for fertility control of animal pests. Our m...
Stock2Me’s latest podcast features M.E. Tuthill, a financial writer and journalist and author of Repo-Madness: A Simpleton’s Guide to the Street’s Wicked Ways, a book aiming to blow the lid off what has come to be known as the shadow banking system.
To begin the interview, Tuthill discussed her background.
“I was born and raised outside of Boston, Massachusetts, and I spent the earlier part of my career in broadcasting as a radio j...
Stock2Me’s latest podcast features M.E. Tuthill, a financial writer and journalist and author of Repo-Madness: A Simpleton’s Guide to the Street’s Wicked Ways, a book aiming to blow the lid off what has come to be known as the shadow banking system.
To begin the interview, Tuthill discussed her background.
“I was born and raised outside of Boston, Massachusetts, and I spent the earlier part of my career in broadcasting as a radio j...
Stock2Me’s latest podcast features the return of David Jemmett, CEO and Founder of CISO Global Inc. (NASDAQ: CISO), an industry leader in cybersecurity and compliance services.
Throughout the interview, Jemmett discussed the current state of the cybersecurity industry and CISO’s expanding position within it.
“Here’s a rhetorical question: Are we doing cybersecurity correctly today? No. With $6 trillion lost ...
Stock2Me’s latest podcast features the return of David Jemmett, CEO and Founder of CISO Global Inc. (NASDAQ: CISO), an industry leader in cybersecurity and compliance services.
Throughout the interview, Jemmett discussed the current state of the cybersecurity industry and CISO’s expanding position within it.
“Here’s a rhetorical question: Are we doing cybersecurity correctly today? No. With $6 trillion lost last year, we only spent...
Stock2Me’s latest podcast features Rod Turner, CEO and Founder of Manhattan Street Capital, the premier growth capital platform for midsize and startup companies.
Throughout the interview, Turner discussed his professional background – from his time as an engineer to his successful track record as an entrepreneur – before examining why he founded Manhattan Street Capital.
“In March 2015, Reg A+ was announced, and it went effective ...
Stock2Me’s latest podcast features Rod Turner, CEO and Founder of Manhattan Street Capital, the premier growth capital platform for midsize and startup companies.
Throughout the interview, Turner discussed his professional background – from his time as an engineer to his successful track record as an entrepreneur – before examining why he founded Manhattan Street Capital.
“In March 2015, Reg A+ was announced, and it went effective ...
Stock2Me’s latest podcast features David Jemmett, CEO and Founder of Cerberus Cyber Sentinel Corp. (NASDAQ: CISO) (“CISO Global” or the “Company”), an industry leader in cybersecurity and compliance services.
Throughout the interview, Jemmett discussed the core values and mission of Cerberus Sentinel.
“Cerberus Sentinel was founded at a period of time when there were 800,000 job openings in cyber. There’s been a zero jobless rate s...
Stock2Me’s latest podcast features Amir Reichman, CEO of BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV), a biotechnology company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious diseases and autoimmune diseases.
In this podcast episode, Reichman introduced the history of BiondVax leading up to his appointment as CEO before discussing the company’...
Stock2Me’s latest podcast features Amir Reichman, CEO of BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV), a biotechnology company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious diseases and autoimmune diseases.
In this podcast episode, Reichman introduced the history of BiondVax leading up to his appointment as CEO before discussing the company’...
Stock2Me’s latest podcast features two-time Olympic gold medalist Abby Wambach speaking on behalf of Odyssey Health Inc. (OTC: ODYY), a medical technology company developing a drug/device combination intended to treat concussion. Wambach is a member of Odyssey’s sports advisory board, which aims to support the company’s efforts to enhance public awareness of traumatic brain injuries and concussions, as well as the need for an FDA-a...
Stock2Me’s latest podcast features two-time Olympic gold medalist Abby Wambach speaking on behalf of Odyssey Health Inc. (OTC: ODYY), a medical technology company developing a drug/device combination intended to treat concussion. Wambach is a member of Odyssey’s sports advisory board, which aims to support the company’s efforts to enhance public awareness of traumatic brain injuries and concussions, as well as the need for an FDA-a...
Stock2Me’s latest podcast features the return of Ian Clifford, CEO of FuelPositive Corp. (TSX.V: NHHH) (OTCQB: NHHHF), a growth stage company committed to providing commercially viable and sustainable “cradle to cradle” clean technology solutions, including green ammonia (NH3), for use across a broad spectrum of industries and applications.
Throughout the interview, Clifford discussed FuelPositive’s rapid development throughout 20...
Stock2Me’s latest podcast features the return of Ian Clifford, CEO of FuelPositive Corp. (TSX.V: NHHH) (OTCQB: NHHHF), a growth stage company committed to providing commercially viable and sustainable “cradle to cradle” clean technology solutions, including green ammonia (NH3), for use across a broad spectrum of industries and applications.
Throughout the interview, Clifford discussed FuelPositive’s rapid development throughout 20...
Stock2Me’s latest podcast features Chris Bunka, Chairman & CEO of Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms.
To begin the interview, Bunka provided a summary of Lexaria’s business model, which is focused on leveraging the company’s proprietary DehydraTECH™ drug delivery technology.
“[Lexaria has] developed a drug delivery technology that’s quite unique,” Bunka said. “What our technology ...
Stock2Me’s latest podcast features Chris Bunka, Chairman & CEO of Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms.
To begin the interview, Bunka provided a summary of Lexaria’s business model, which is focused on leveraging the company’s proprietary DehydraTECH™ drug delivery technology.
“[Lexaria has] developed a drug delivery technology that’s quite unique,” Bunka said. “What our technology ...
Stock2Me’s latest podcast features Ian Clifford, CEO of FuelPositive Corp. (TSX.V: NHHH) (OTCQB: NHHHF), a growth stage company focused on manufacturing, licensing, partnership and acquisition opportunities building upon various technological achievements.
Throughout the interview, Clifford discussed FuelPositive’s innovative carbon-free ammonia technology and its potential to change the energy landscape, both across Canada and aro...
Popular Podcasts
Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations.
Anna Sale explores the big questions and hard choices that are often left out of polite conversation.
If you've ever wanted to know about champagne, satanism, the Stonewall Uprising, chaos theory, LSD, El Nino, true crime and Rosa Parks, then look no further. Josh and Chuck have you covered.
If you can never get enough true crime... Congratulations, you’ve found your people.
A straightforward look at the day's top news in 20 minutes. Powered by ABC News. Hosted by Brad Mielke.